Pre-earnings options volume in Iovance Biotherapeutics (IOVA) is 1.2x normal with calls leading puts 4:3. Implied volatility suggests the market is anticipating a move near 23.8%, or 62c, after results are released. Median move over the past eight quarters is 16.0%.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IOVA:
- Iovance Biotherapeutics Advances Lifileucel Study for Endometrial Cancer
- Unusually active option classes on open July 23rd
- Iovance Biotherapeutics Gains Competitive Edge as Replimune Faces FDA Setback
- Realty Income, GitLab, DoorDash, Iovance, Senseonics: Trending by Analysts
- Iovance Biotherapeutics Appoints New Chief Financial Officer